- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02745873
Lead Detoxifying Effects of Ascorbic Acid Among School Going Adolescents of Karachi- A Cluster Randomized Control Trial (LDVC)
Study Overview
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1-school going adolescents, aged 13-18 years.
Exclusion Criteria:
- Children with history or presence of chronic illness or bleeding disorders, requiring red blood cell transfusion, dialysis
- Using multivitamins
- Those who planning to leave study place within 2 months of start of study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm A
Ascorbic Acid 250 mg in tablet form was used.
|
Ascorbic Acid (vitamin-c) 500 mg in tablet form was used.
Other Names:
|
Experimental: Arm B
Ascorbic Acid 500 mg in tablet form was used.
|
Ascorbic Acid (vitamin-c) 500 mg in tablet form was used.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Lead Level
Time Frame: 4 weeks
|
Mean Change in blood lead level is the main outcome of the study. It will be recorded as continuous variable and unit of measurement will be μg/dl. Blood lead levels will be assessed at baseline before the start of intervention and at the end of the 4 weeks of intervention period in both arms. Mean change will be calculated by taking difference between two the points as follow up (4 weeks) Blood lead levels minus baseline Blood Lead level. |
4 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LDVC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elevated Blood Lead Levels
-
Novozymes A/SUniversidad Iberoamericana A.C., Mexico; Linus Biotechnology IncCompletedEffect of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Young Women of Child-bearing AgeElevated Blood Lead LevelsMexico
-
Novozymes A/SBeijing Children's Hospital; Chengdu Women's and Children's Central Hospital; Beijing Clinical Service Center and other collaboratorsCompletedElevated Blood Lead LevelsChina
-
Zimmer BiometUnknownTissue Reaction | Elevated Blood Ion LevelsUnited States
-
Nonin Medical, IncCompleted
-
Charite University, Berlin, GermanyUnknownElevated Lipoprotein(a) LevelsGermany
-
Nonin Medical, IncUniversity of California, San FranciscoCompleted
-
Unilever R&DCompletedHealthy | Mildly Elevated Cholesterol LevelsSweden
-
KGK Science Inc.Healthy Directions, LLCCompletedCoQ10 Blood Levels | CoQ10 Blood Levels With Statin UseCanada
-
Tel-Aviv Sourasky Medical CenterUnknownBlood Antibiotic Levels
-
University of British ColumbiaMasimo CorporationCompletedHemoglobin Levels in BloodCanada
Clinical Trials on Ascorbic Acid
-
Harokopio UniversityCompletedSymptomatic Knee OsteoarthritisGreece
-
Situs Cancer Research CenterSuspendedSarcoma | Adenocarcinoma | Carcinoma | Multiple Myeloma | Desmoplastic Small Round Cell TumorUnited States
-
DongGuk UniversityKorean Association For Vitamin ResearchCompleted
-
National Taiwan University Hospital Hsin-Chu BranchCompletedHemodialysis Access Failure
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedCovid19 | Respiratory Distress Syndrome, AdultTurkey
-
Swiss Federal Institute of TechnologyCompletedIron-deficiency | Iron Deficiency AnemiaSwitzerland
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Unknown
-
Jewish General HospitalCompleted
-
Cairo UniversityCompletedPalatally Impacted CaninesEgypt